E2F1 and astrocytoma (excluding glioblastoma): In addition, it was shown that an increased expression of the transcription factor E2F1 and glycogen synthase kinase-3B correlated with the level of LSH in astrocytomas and GBM, also leading to an increased progression of the disease (56).